Drug: |
BGT226 |
|||
---|---|---|---|---|
Trial: |
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Completed |
Cancer Therapy and Research Center7979 Wurzbach Rd. |
Principal Investigator: |
Francis Giles, MD |
---|---|
Contact: |
Epp Goodwin 210-450-5798 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cancer Therapy and Research Center Website: |
http://www.ctrc.net/research/clinicalname.cfm |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.